UK Space Biomed Consortium

英国太空生物医学联盟

• 批准号: 750074
• 金额: $ 1.02万
• 依托单位: UK SPACE BIOMEDICINE CONSORTIUM
• 依托单位国家: 英国
• 项目类别: Vouchers
• 财政年份: 2012
• 资助国家: 英国
• 起止时间: 2012 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=750074
• 关键词: UK; Space; Biomed; Consortium

A UK Space Biomedicine Strategy for the Benefit of the UKThe UK Space Biomedicine Consortium consists of 27 establishments from a number of academic organisations and industrial companies from across the UK. The Consortium is in the process of identifying, and will propose, ratify and subsequently pursue a strategy centred upon augmented communication, coordination and collaboration between academic and industrial, and where appropriate, Governmental, organisations. The strategy aims to formally establish and develop space biomedicine as a field within the UK. It will focus the resources of the UK Space Biomedicine Consortium members (and any future members) to enable the following aims to be achieved. AIMSi. Benefit terrestrial healthcare. ii. Enhance UK innovation and economic growth. iii. Prepare the UK to effectively participate in future human spaceflight activities. iv. Benefit / serve the interests of UKSBC members.v. Contribute to, and benefit from, international collaboration.Vision The members of the UK Space Biomedicine Consortium will embark upon a course of action that shall result in the official recognition of the domain of space biomedicine within the UK. The space biomedicine activities coordinated by the Consortium and undertaken across the nation will diminish the negative impact of an ageing population, improve terrestrial healthcare provision and prepare the country for the new space era that approaches (one based upon commercial human spaceflight). The UK Space Biomedicine Consortium intends to establish itself as an Institute with members drawn from academia and industry, who shall develop 4 R&D and commercial product programmes according to the following themes;1. Ageing, Lifestyle & Nutrition2. Telemedicine / e-Health / Biotechnology 3. Morbidity in relation to space travel. 4. Human Factors and Performance.

英国空间生物医学联盟由来自英国各地的一些学术组织和工业公司的27个机构组成。该联合会正在确定并将提出、批准和随后实施一项战略，该战略的核心是加强学术界和工业界以及适当时政府组织之间的沟通、协调和合作。该战略旨在正式建立和发展空间生物医学作为联合王国的一个领域。它将集中联合王国空间生物医学联合会成员（和任何未来成员）的资源，以实现以下目标。目标有益于陆地卫生保健。二.促进英国创新和经济增长。三.为英国有效参与未来的载人航天活动做好准备。四.联合王国空间生物医学联合会的成员将着手采取行动，最终使联合王国空间生物医学领域得到正式承认。由该联合会协调并在全国范围内开展的空间生物医学活动将减少人口老龄化的负面影响，改善地面医疗保健的提供，并使国家为即将到来的新空间时代（基于商业载人航天飞行的时代）做好准备。英国空间生物医学联合会打算将自己建立为一个研究所，成员来自学术界和工业界，他们将根据以下主题开发4个研发和商业产品计划：1。老龄化、生活方式和营养2.远程医疗/电子保健/生物技术3.与太空旅行有关。4.人为因素和性能。